Genes, endothelial function and cerebral small vessel disease in man

Area of Science:

• Neurology
• Vascular Biology
• Genetics

Background:

• Cerebral small vessel disease (CSVD) causes ischemic damage to white matter and deep gray matter nuclei.
• It manifests as focal lacunar infarction and diffuse chronic ischemia (leukoaraiosis).
• Two subtypes are proposed: isolated lacunar infarction and ischemic leukoaraiosis, often linked to hypertension.

Purpose of the Study:

• To explore the underlying mechanisms and potential subtypes of cerebral small vessel disease.
• To investigate the role of endothelial dysfunction and genetic predispositions in CSVD pathogenesis.
• To identify robust and replicable risk factors for CSVD.

Main Methods:

• Review of existing literature on CSVD pathophysiology.
• Analysis of evidence linking endothelial activation and dysfunction to CSVD.
• Examination of genetic association studies, including genes related to the renin-angiotensin system, endothelial nitric oxide, and homocysteine.

Main Results:

• CSVD subtypes may include isolated lacunar infarction (linked to microatheroma) and ischemic leukoaraiosis (linked to diffuse arteriopathy and hypertension).
• Evidence suggests endothelial activation and dysfunction contribute to CSVD.
• Genetic factors, particularly those influencing endothelial function, are implicated, though associations require further validation.

Conclusions:

• Cerebral small vessel disease likely comprises distinct subtypes with different underlying pathologies.
• Endothelial dysfunction and genetic predisposition are significant areas of investigation for CSVD.
• Larger, robust studies are necessary to confirm specific genetic associations and establish definitive risk factors for CSVD.